ストックスクリーナーアプリを入手
2.87
24.24%
0.56
プレマーケット:
2.89
0.02
+0.70%
前日終値:
$2.31
開ける：
$2.33
24時間の取引高:
4.55M
Relative Volume:
9.09
時価総額：
$42.77M
収益：
$160.43M
当期純損益:
$-227.64M
株価収益率:
-0.0417
EPS:
-68.77
ネットキャッシュフロー:
$-170.79M
1週間 パフォーマンス:
+69.82%
1か月 パフォーマンス:
+78.26%
6か月 パフォーマンス:
-36.08%
1年 パフォーマンス:
-50.26%
1日の値動き範囲:
$2.28
$3.30
1週間の範囲:
$1.60
$3.30
52週間の値動き範囲:
$1.38
$19.69
Agenus Inc Stock (AGEN) Company Profile
AGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
2.87 | 42.77M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
490.47 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.49 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
599.87 | 36.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
236.75 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
252.77 | 25.74B | 3.81B | -644.79M | -669.77M | -6.24 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | 開始されました | Robert W. Baird | Outperform |
| 2023-02-28 | 再開されました | H.C. Wainwright | Buy |
| 2022-09-28 | 開始されました | SMBC Nikko | Outperform |
| 2021-12-16 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-19 | 再開されました | B. Riley FBR | Buy |
| 2019-04-22 | 開始されました | B. Riley FBR | Buy |
| 2016-10-28 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | 繰り返されました | Maxim Group | Buy |
| 2016-03-11 | アップグレード | Maxim Group | Hold → Buy |
| 2015-12-16 | 開始されました | Jefferies | Buy |
| 2015-10-27 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-07-27 | 繰り返されました | MLV & Co | Buy |
| 2015-06-11 | 開始されました | Oppenheimer | Outperform |
| 2015-01-12 | 繰り返されました | Maxim Group | Buy |
| 2015-01-09 | 繰り返されました | MLV & Co | Buy |
| 2015-01-09 | 繰り返されました | Maxim Group | Buy |
| 2014-12-19 | 繰り返されました | Maxim Group | Buy |
| 2014-05-08 | 繰り返されました | Maxim Group | Buy |
| 2014-03-14 | 繰り返されました | MLV & Co | Buy |
| 2013-10-08 | 繰り返されました | Maxim Group | Buy |
| 2012-01-05 | 開始されました | William Blair | Outperform |
| 2011-12-01 | 開始されました | Global Hunter Securities | Buy |
すべてを表示
Agenus Inc (AGEN) 最新ニュース
Press Release Distribution & PR Platform - ACCESS Newswire
Agenus (AGEN) Price Target Slashed by B. Riley Analyst, Buy Rating Maintained | AGEN Stock News - GuruFocus
B. Riley Cuts Price Target on Agenus to $8 From $11, Keeps Buy Rating - marketscreener.com
Agenus Inc. (AGEN) to Present Key Cancer Research at AACR Meeting - GuruFocus
AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Agenus stock hits 52-week low at $1.44 amid sharp annual decline - Investing.com Australia
Agenus stock hits 52-week low at $1.44 amid sharp annual decline By Investing.com - Investing.com South Africa
AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Agenus Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
Agenus Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - ACCESS Newswire
Agenus stock hits 52-week low at $1.53 amid sharp annual decline By Investing.com - Investing.com South Africa
Agenus stock hits 52-week low at $1.53 amid sharp annual decline - Investing.com India
Breakthrough Cancer Treatment Data: Agenus BOT/BAL Shows Promise Across Multiple Cancers - Stock Titan
Here's Why Agenus (AGEN) Is a Great 'Buy the Bottom' Stock Now - Nasdaq
Agenus stock hits 52-week low at $1.64 amid sharp annual decline By Investing.com - Investing.com South Africa
Agenus stock hits 52-week low at $1.64 amid sharp annual decline - Investing.com Australia
Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation - Lelezard
93% of Doctors Say Current Colorectal Cancer Treatments Fall Short, New Study Shows - Stock Titan
H.C. Wainwright maintains neutral on Agenus stock post-10-K filing - Investing.com Australia
AGENUS INC SEC 10-K Report - TradingView
Gilead Sciences : Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead - Marketscreener.com
Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates - MSN
Equities Analysts Offer Predictions for Agenus Q1 Earnings - Defense World
HC Wainwright Reaffirms Neutral Rating for Agenus (NASDAQ:AGEN) - Defense World
Agenus stock falls after revenue miss - MSN
Agenus (AGEN) Q4 2024 Earnings Call Transcript - AOL
Agenus stock hits 52-week low at $1.91 amid market challenges - Investing.com Australia
Earnings call transcript: Agenus sees stock jump in Q4 2024 By Investing.com - Investing.com Australia
Agenus Inc. Earnings Call: Mixed Sentiments and Strategic Focus - TipRanks
Agenus stock hits 52-week low at $1.91 amid market challenges By Investing.com - Investing.com South Africa
Agenus Inc. (NASDAQ:AGEN) Q4 2024 Earnings Call Transcript - MSN
Agenus’ Strategic Cost Reductions and CRC Focus Lead to Hold Rating - TipRanks
Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges - Yahoo
Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Mo - GuruFocus.com
Agenus Inc. Reports Strategic Cost Reductions and BOT/BAL Progress - TipRanks
Agenus: Q4 Earnings Snapshot - mySA
Agenus stock falls as Q4 revenue drops sharply - Investing.com India
Agenus stock falls as Q4 revenue drops sharply By Investing.com - Investing.com South Africa
Earnings call transcript: Agenus sees stock jump in Q4 2024 - Investing.com India
Agenus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Agenus Inc (AGEN) 財務データ
収益
当期純利益
現金流量
EPS
1.00%
大文字化:
|
ボリューム (24 時間):